May 25, 2017 | By Tess
A team from the Aikenhead Centre for Medical Discovery at St Vincent’s Hospital in Melbourne, Australia has successfully tested its innovative “Biopen.” The 3D bioprinting pen, which can be filled with stem cell hydrogel ink cartridges, was used to repair a sheep’s knee.
The Biopen, which has been in development for some time, could be a significant game-changer for osteoarthritis treatments and prevention, as it could allow doctors to easily print living cells onto injured muscles, bones, tendons, and more.
Professor Peter Choong demonstrating the Biopen
(Image: St Vincent's Hospital)
The device’s body, which features a lightweight and ergonomic structure, is reportedly made from medical grade plastic and titanium. Its titanium nozzle is capable of extruding the bioink, which consists of stem cells and a hydrogel made from gelatin and hyaluronic acid. Once the mixture is extruded, it is cured by a low-powered UV light.
In the recent tests involving a sheep, the Biopen was loaded up with printable ink cartridges filled with the patient’s stem cells and a biocompatible hydrogel material. The hydrogel, said orthopaedic surgeon Claudia Di Bella, not only allows for the cells to be printed, but also enables them to survive and replicate.
Stem cells, which can be adapted to become a range of different cell types, were used to make cartilage cells in this case. "The type of cartilage we were able to create was much superior compared to the other standard techniques we tried in the same sheep, which are the ones used normally in humans," said Di Bella.
The successful tests with the sheep are a positive sign for the technology’s future, as the team behind the Biopen are hopeful that their device will soon be used to repair currently hard-to-treat cartilage injuries. The Biopen could be especially beneficial for young people and athletes, whose injuries could be treated in order to prevent or at least delay the risk of osteoarthritis, the most common chronic joint condition.
Dr. Claudia Di Bella helped develop the Biopen
(Image: Claudia Di Bella)
Osteoarthritis treatments also apparently cost the medical system a huge amount, so having a preventative tool could free up healthcare expenditures significantly. "In the big scheme of things, if we decrease the number of patients that have osteoarthritis later in life, that would incredibly affect the health expenditure of society,” Di Bella explained.
Notably, the 3D printing Biopen was apparently easy to use on the sheep, meaning it should be a relatively straightforward tool for surgeons to adjust to using. Di Bella said: "It would be a fairly [easy], almost stock-standard surgical operation that we do already with a new instrument that is fairly easy to use."
Developed jointly by teams from St Vincent’s, the University of Melbourne, and the University of Wollongong, the Biopen device is currently in the process of being commercialized. We could even see human trials for the 3D bioprinting pen happen within the next year.
Posted in 3D Printing Technology
Maybe you also like:
- T-Bone Cape motion control board launches on Indiegogo
- New extruder could lower costs of 3D printing cellular structures for drug testing
- New Ninja Printer Plate for consumer 3D printing
- mUVe3D releases improved Marlin firmware for all 3D printers
- Zecotek plans HD 3D display for 3D printers
- Add a smart LCD controller to your Robo3D printer
- Maker Kase: a handy cabinet for 3D printers
- Heated bed for ABS printing with the Printrbot Simple XL
- Next gen all metal 3D printer extruder from Micron
- Pico all-metal hotend 100% funded in 48 hours, B3 announces Stretch Goal
- Create it REAL announces first 3D printing Real Time Processor
- A larger and more powerful 3D printer extruder on Kickstarter
What sort of animal is worth such a large sum of money that a arthroscopic surgical procedure could be warranted? It seems such a absurd use of technology for a cartilage repair tissue. Surely a injection into the joint would be a lot simpler. Maybe try a enhanced Synvisc and sulphate sugar solution that supports and repairs the cartilage as it reacts with the synovial fluid.